Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 23

Trial Status

Completed1
Other2

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT03561584Phase 2Completed
Sulfasalazine for the Treatment of Primary Sclerosing Cholangitis
Primary Sclerosing Cholangitis
PrincipalinvestigatorStart date: 2018-07-01
NCT07898839Phase 2Not Yet Recruiting
FEAST and HOPE: Redox PSC Pilot Study
Primary Sclerosing Cholangitis (PSC)
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Brigham and Women's Hospital

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT03561584Phase 2PrincipalInvestigator

Sulfasalazine for the Treatment of Primary Sclerosing Cholangitis

Primary Sclerosing Cholangitis
Completed
NCT04259060Phase 2PrincipalInvestigator

Hydroxocobalamin Approach for Reducing of Calprotectin With Butyrate for Ulcerative Colitis Remission

Ulcerative Colitis
Withdrawn
NCT07898839Phase 2PrincipalInvestigator

FEAST and HOPE: Redox PSC Pilot Study

Primary Sclerosing Cholangitis (PSC)
Not Yet Recruiting

All 3 trials loaded